New study to test long-term effects of weight loss drugs
Ozempic, Wegovy, Mounjaro — three new medications used to treat obesity — seemed to be all over the news and social media in 2023. You’ve likely seen or read about their effectiveness, their side effects, their cost and what happens when you quit taking them. But as we grapple with the increasing epidemic of obesity an d its complementary health issues, researchers at Wake Forest University School of Medicine are looking to an older, generic drug for answers.
First approved by the Food and… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 14, 2024 Category: Biotechnology Authors: Atrium Health Wake Forest Baptist Source Type: news
Nvidia Leads 5 Stocks Near Buy Points As S & P 500 Tests Key Level
and uranium producer Cameco (CCJ) lead this weekend's watch list of five stocks near buy points. Both NVDA and CCJ bucked the trend over the past week as the S&P 500 slipped back to its 50-day moving average for the first time since early November. The list also includes obesity drug leader Novo…#nvda #novonordisk #nvo #aresmanagement #nvidia #ibdleaderboard #swingtrader #ibdstockcheckup #treasury #intel (Source: Reuters: Health)
Source: Reuters: Health - April 13, 2024 Category: Consumer Health News Source Type: news
Endoscopic Sleeve Gastroplasty Is Cost Saving Versus Semaglutide
FRIDAY, April 12, 2024 -- For individuals with class II obesity, endoscopic sleeve gastroplasty (ESG) is cost saving compared with semaglutide, according to a study published online April 12 in JAMA Network Open.Muhammad Haseeb, M.D., from Brigham... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2024 Category: Pharmaceuticals Source Type: news
Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+
(MedPage Today) -- A certain type of bariatric surgery may prove more cost-effective over time than a popular weight loss drug, an economic evaluation study suggested.
In an analysis of adults with class II obesity (BMI 35-39.9), endoscopic sleeve... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - April 12, 2024 Category: Surgery Source Type: news
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has determined that there is no substantial evidence supporting a link between Glucagon-Like Peptide-1 receptor agonists (GLP-1) and suicidal or self-injurious thoughts and behaviors. The assessment comes following…#glp1 #fda #obese #saxenda #xultophy #sanofisas #snylyxumia #suliqua #elilillyand #cosllytrulicity (Source: Reuters: Health)
Source: Reuters: Health - April 12, 2024 Category: Consumer Health News Source Type: news
Semaglutide Benefits in HFpEF Step Beyond Weight Loss Semaglutide Benefits in HFpEF Step Beyond Weight Loss
Drs Pi ña and Kosiborod discuss semaglutide in obesity-related HF with and without diabetes. Both STEP HFpEF trials show similar HF benefits despite less weight loss in patients with diabetes.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 12, 2024 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Average size of women's butts around the world revealed: US fails to crack top 5 and UK is nowhere near top
America has a reputation for plastic surgery and obesity, but South African women have the biggest backsides, data collected by market research company GitNux found. The US took sixth place. (Source: the Mail online | Health)
Source: the Mail online | Health - April 12, 2024 Category: Consumer Health News Source Type: news
Is it better to workout before or after work? Fitness experts reveal the part of the day when you'll burn the most calories
A major new study showed that exercising at night reduced obese peoples risk of death by over 60 percent, and risk of heart disease by over 36 percent. (Source: the Mail online | Health)
Source: the Mail online | Health - April 11, 2024 Category: Consumer Health News Source Type: news
Why a New Study Dubbed India the ‘Cancer Capital of the World’
A new study has unveiled an alarming picture of declining overall health in India. The report, released by the Indian multinational healthcare group, Apollo Hospitals, found that skyrocketing cases of cancer and other non-communicable diseases across the country have now made it “the cancer capital of the world.”
[time-brightcove not-tgx=”true”]
Despite reporting more than a million new cases every year, India’s cancer rate has not yet surpassed countries like Denmark, Ireland, and Belgium, which record some of the highest cancer rates in the world. It is also currently lower than the U.S....
Source: TIME: Health - April 10, 2024 Category: Consumer Health News Authors: Astha Rajvanshi Tags: Uncategorized India Source Type: news
Should I Take Supplements to Sleep? What Experts Think
If you want to understand the importance of sleep, ask someone who spent the previous night tossing and turning. Sleep is a vital function: essential for physical recovery, preparing for the next day, even clearing waste material from the brain. Mounting evidence suggests that getting adequate amounts of sleep each night is even more critical than previously believed, responsible for reducing the risk of serious conditions including dementia, obesity, and stroke.
[time-brightcove not-tgx=”true”]
Yet so many of us struggle to fall and stay asleep, with more than one-third of U.S. adults failing to get the re...
Source: TIME: Health - April 10, 2024 Category: Consumer Health News Authors: Carly Weeks Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news
Bargain Alert: Apple Shares Are Starting To Look Undervalued - Apple (NASDAQ:AAPL), Amazon.com (NASDAQ:AM
It's been a funny couple of months for shares of Apple Inc AAPL. Traditionally, one of the market leaders who you could nearly bet would be moving in lock-step with the likes of Meta Platforms META or Amazon.com Inc AMZN, this year has seen the iPhone maker's fortunes diverge significantly from…#appleincaapl #metaplatforms #iphone #apple #amazon #meta #shermanact #timcook #motherofallai #overweight (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2024 Category: Consumer Health News Source Type: news
The Dying Brain; Obesity Drugs and MS; NurOwn Tries Again
(MedPage Today) -- New research about the dying brain suggested the line between consciousness and death may not be distinct. (The Guardian)
A single fecal microbiota transplantation induced mild but sustained effects on motor symptoms in early... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - April 9, 2024 Category: Neurology Source Type: news
Managing Obesity: More Than GLP-1s or Bust Managing Obesity: More Than GLP-1s or Bust
Obesity expert Dr Holly Lofton reviews three alternatives to GLP-1s to help patients drop excess weight.Medscape Internal Medicine (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 9, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
America ’ s Growing Birthweight Crisis
Americans are increasingly at risk of having lower incomes, poorer health, and a worse shot at opportunity even before they are born. More babies are now born with low birthweights than in the last 30 years. This has caused growing inequalities that can persist if not properly addressed. In certain parts of the country, that risk may be ten-times greater.
Underweight newborns are at an increased risk of long term health challenges, lower IQ scores, and developmental delays. New data shows that the frequency of this problem is rising with more than 300,000 newborns now experiencing low birthweight. This public hea...
Source: TIME: Health - April 9, 2024 Category: Consumer Health News Authors: Jeremy Ney Tags: Uncategorized freelance Source Type: news
ACC: Semaglutide Beneficial in Obesity-Related Heart Failure, Type 2 Diabetes
TUESDAY, April 9, 2024 -- Semaglutide leads to larger reductions in heart failure-related symptoms and physical limitations among patients with obesity-related heart failure with preserved ejection fraction and type 2 diabetes, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2024 Category: Pharmaceuticals Source Type: news
